Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sorafenib in Urothelium Cancer of Bladder

This study has been terminated.
(Slow recruitment)
University Hospital, Essen
Information provided by (Responsible Party):
Association of Urogenital Oncology (AUO) Identifier:
First received: October 1, 2010
Last updated: September 7, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)